image
Adaptimmune Therapeutics plc ADAP
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 0.2765
1.08 %
$ 71.3 M
Market Cap
-0.93
P/E
Price Target Average
994.03%
Revenue Forecast Estimate
7.46%
EBIT Estimate
--31.71%
Net Income Estimate
19.97%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Adaptimmune Therapeutics plc
image
Wall Street analysts predict an average 1-year price target for ADAP of $3.02 , with forecasts ranging from a low of $1 to a high of $4 .
ADAP Lowest Price Target Wall Street Target
1 USD 261.66%
ADAP Average Price Target Wall Street Target
3.02 USD 994.03%
ADAP Highest Price Target Wall Street Target
4 USD 1346.65%
Price
Max Price Target
Min Price Target
Average Price Target
444433332222111100Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart ADAP

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ADAP

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ADAP

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029